Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-009968
Filing Date
2025-01-28
Accepted
2025-01-28 17:31:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13025
  Complete submission text file 0000950170-25-009968.txt   15037
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 25565924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2800 POST OAK BLVD. SUITE 2000 HOUSTON TX 77056
Business Address 2800 POST OAK BLVD. SUITE 2000 HOUSTON TX 77056 713-961-0118
Freebird Partners LP (Filed by) CIK: 0001955231 (see all company filings)

EIN.: 331028238 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13G/A